Julie A. Johnson, Pharm.D., is Dean of the University of Florida College of Pharmacy (since 2013) and Distinguished Professor of Pharmacy and Medicine. She received her B.S. in Pharmacy from the Ohio State University, her Pharm.D. from the University of Texas at Austin and the UT HSC in San Antonio, and completed a post-doctoral fellowship in cardiovascular pharmacology/ pharmacokinetics at Ohio State. Dr. Johnson’s research focuses on cardiovascular pharmacogenomics and genomic medicine implementation. She is an internationally-recognized leader in pharmacogenomics and genomic medicine, with over 300 peer reviewed publications and over $44M in research funding as principal investigator. In 2015, 2016 and 2017 she was a Clarivate Analytics Highly Cited Scientist in Pharmacology and Toxicology, and in 2018 in the Cross Discipline category, indicating she is in the top 1% of the most highly cited scientists in the field globally. Dr. Johnson has served in numerous capacities with the NIH, the Food and Drug Administration and leadership roles in multiple professional societies, including as President of the American Society of Clinical Pharmacology and Therapeutics. Dr. Johnson’s awards and honors include election to the National Academy of Medicine, teaching awards from the University of Tennessee and the University of Florida, the American Association of Colleges of Pharmacy Therapeutic Frontiers Award, the Southeastern Universities Research Association Distinguished Scientist Award, the American Association of Colleges of Pharmacy Volwiler Research Achievement Award, among others.